| scholarly article | Q13442814 |
| P356 | DOI | 10.1053/CGH.2003.50019 |
| P698 | PubMed publication ID | 15017503 |
| P50 | author | Duane Burton | Q89104732 |
| Sanna McKinzie | Q116781678 | ||
| George M Thomforde | Q116781700 | ||
| Alan R. Zinsmeister | Q64368056 | ||
| Michael Camilleri | Q64750736 | ||
| P2093 | author name string | Phillip A Low | |
| Doe-Young Kim | |||
| H Jae Kim | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | diarrhea | Q40878 |
| P304 | page(s) | 111-121 | |
| P577 | publication date | 2003-03-01 | |
| P1433 | published in | Clinical Gastroenterology and Hepatology | Q5133759 |
| P1476 | title | A randomized, controlled exploratory study of clonidine in diarrhea-predominant irritable bowel syndrome | |
| P478 | volume | 1 |
| Q88947138 | A pharmacological challenge predicts reversible rectal sensorimotor dysfunctions in women with fecal incontinence |
| Q37290311 | A randomized controlled trial of imipramine in patients with irritable bowel syndrome |
| Q37142056 | A review of irritable bowel syndrome and an update on therapeutic approaches |
| Q46923413 | An exploratory study of the association of adrenergic and serotonergic genotype and gastrointestinal motor functions |
| Q37552802 | An update on anorectal disorders for gastroenterologists |
| Q35596567 | Association of distinct alpha(2) adrenoceptor and serotonin transporter polymorphisms with constipation and somatic symptoms in functional gastrointestinal disorders |
| Q34557903 | Chronic Diarrhea |
| Q85478405 | Clinical Challenges of Fecal Incontinence in the Elderly |
| Q38919181 | Common Functional Gastroenterological Disorders Associated With Abdominal Pain |
| Q37438547 | Current and novel therapeutic options for irritable bowel syndrome management |
| Q33435562 | Current gut-directed therapies for irritable bowel syndrome |
| Q35215213 | Effects of Hypericum perforatum extract on rat irritable bowel syndrome. |
| Q37510329 | Effects of clonidine in women with fecal incontinence |
| Q36458417 | Emerging drugs for irritable bowel syndrome |
| Q34036175 | Evidence for alterations in central noradrenergic signaling in irritable bowel syndrome |
| Q49677641 | Existing and emerging therapies for managing constipation and diarrhea |
| Q30433078 | Functional GI disorders: from animal models to drug development |
| Q34473834 | Genetics and pharmacogenetics of aminergic transmitter pathways in functional gastrointestinal disorders. |
| Q36779337 | IBS--review and what's new. |
| Q34116812 | Investigation of the distribution and function of alpha-adrenoceptors in the sheep isolated internal anal sphincter |
| Q37788218 | Investigational agents for the irritable bowel syndrome. |
| Q36514156 | Irritable bowel syndrome: recent and novel therapeutic approaches |
| Q34660338 | Irritable bowel syndrome: the evolution of multi-dimensional looking and multidisciplinary treatments |
| Q36556549 | Irritable bowel syndrome: update on colonic neuromuscular dysfunction and treatment |
| Q37002201 | Novel therapeutic approaches in IBS. |
| Q37846099 | Opioid-induced constipation: challenges and therapeutic opportunities |
| Q37212893 | Pharmacogenetics of low dose clonidine in irritable bowel syndrome |
| Q37071175 | Recent developments in the therapy of irritable bowel syndrome |
| Q36072575 | Review article: drugs interfering with visceral sensitivity for the treatment of functional gastrointestinal disorders--the clinical evidence |
| Q36583822 | Review article: modulation of the brain-gut axis as a therapeutic approach in gastrointestinal disease |
| Q36728938 | Serotonergic and non-serotonergic targets in the pharmacotherapy of visceral hypersensitivity |
| Q36536707 | Systematic review: the efficacy of treatments for irritable bowel syndrome--a European perspective |
| Q36536709 | Systematic review: the safety and tolerability of pharmacological agents for treatment of irritable bowel syndrome--a European perspective |
| Q34101459 | The effects of clonidine on symptoms and anorectal sensorimotor function in women with faecal incontinence |
| Q36136622 | The narcotic bowel syndrome: clinical features, pathophysiology, and management |
| Q34421382 | The placebo effect in irritable bowel syndrome trials: a meta-analysis |
| Q35047051 | Treating irritable bowel syndrome: overview, perspective and future therapies |
| Q33450370 | Treatment of irritable bowel syndrome. |
| Q36304083 | Treatments targeting putative mechanisms in irritable bowel syndrome |
| Q37156627 | Updates on treatment of irritable bowel syndrome |
| Q37118821 | Visceral analgesics: drugs with a great potential in functional disorders? |
| Q36793828 | What about clonidine for diarrhoea? A systematic review and meta-analysis of its effect in humans |
Search more.